Q1 2026 Holdings
Filed 2026-05-04 | 23 holdings | $632.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $155.1M | 4,763,673 | 24.5% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $151.3M | 10,763,288 | 23.9% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $127.4M | 8,963,500 | 20.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $88.3M | 2,611,568 | 14.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $36.1M | 1,880,303 | 5.7% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $18.4M | 6,998,902 | 2.9% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $17.4M | 1,538,296 | 2.8% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $8.1M | 8,019,148 | 1.3% |
| Xencor Inc(XNCR) | COM | 98401F105 | $6.5M | 536,398 | 1.0% |
| Precision Biosciences Inc(DTIL) | COM NEW | 74019P207 | $5.4M | 985,113 | 0.9% |
| Passage BIO Inc(PASG) | COM NEW | 702712209 | $4.9M | 623,704 | 0.8% |
| Neuphoria Therapeutics Inc(NEUP) | COM | 64136E102 | $3.6M | 875,328 | 0.6% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $2.7M | 211,689 | 0.4% |
| CG Oncology Inc(CGON) | COM | 156944100 | $2.1M | 31,591 | 0.3% |
| Immatics N.v(IMTX) | SHS | N44445109 | $2.1M | 216,973 | 0.3% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $1.3M | 119,516 | 0.2% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $973.1K | 1,628,700 | 0.2% |
| Werewolf Therapeutics Inc(HOWL) | COM | 95075A107 | $547.7K | 657,786 | 0.1% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $129.3K | 68,076 | 0.0% |
| Bolt Biotherapeutics Inc(BOLT) | COM NEW | 097702203 | $124.4K | 30,800 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $110.9K | 68,486 | 0.0% |
| Absci Corporation(ABSI) | COM | 00091E109 | $63.7K | 21,245 | 0.0% |
| Traws Pharma Inc(TRAW) | COM NEW | 68232V884 | $27.6K | 15,078 | 0.0% |